Vontobel Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Buy |
2,917
+1,226
| +73% | +$400K | ﹤0.01% | 602 |
|
|
2025
Q1 | $457K | Sell |
1,691
-113
| -6% | -$30.5K | ﹤0.01% | 811 |
|
|
2024
Q4 | $424K | Sell |
1,804
-5,460
| -75% | -$1.28M | ﹤0.01% | 836 |
|
|
2024
Q3 | $2M | Sell |
7,264
-1,149
| -14% | -$316K | 0.01% | 449 |
|
|
2024
Q2 | $2.04M | Sell |
8,413
-278
| -3% | -$67.6K | 0.01% | 425 |
|
|
2024
Q1 | $1.3M | Sell |
8,691
-242
| -3% | -$36.2K | 0.01% | 517 |
|
|
2023
Q4 | $1.71M | Buy |
8,933
+5,109
| +134% | +$978K | 0.01% | 464 |
|
|
2023
Q3 | $677K | Sell |
3,824
-70
| -2% | -$12.4K | 0.01% | 680 |
|
|
2023
Q2 | $740K | Sell |
3,894
-740
| -16% | -$141K | 0.01% | 686 |
|
|
2023
Q1 | $928K | Sell |
4,634
-671
| -13% | -$134K | 0.01% | 606 |
|
|
2022
Q4 | $1.23M | Buy |
5,305
+459
| +9% | +$106K | 0.01% | 520 |
|
|
2022
Q3 | $1.02M | Sell |
4,846
-557
| -10% | -$117K | 0.01% | 543 |
|
|
2022
Q2 | $786K | Sell |
5,403
-1,043
| -16% | -$152K | 0.01% | 597 |
|
|
2022
Q1 | $1.07M | Sell |
6,446
-790
| -11% | -$131K | 0.01% | 597 |
|
|
2021
Q4 | $1.24M | Buy |
7,236
+3,991
| +123% | +$682K | 0.01% | 573 |
|
|
2021
Q3 | $612K | Buy |
3,245
+1,114
| +52% | +$210K | 0.01% | 732 |
|
|
2021
Q2 | $354K | Sell |
2,131
-45
| -2% | -$7.48K | ﹤0.01% | 864 |
|
|
2021
Q1 | $307K | Hold |
2,176
| – | – | ﹤0.01% | 798 |
|
|
2020
Q4 | $359K | Buy |
+2,176
| New | +$359K | ﹤0.01% | 710 |
|